NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOIIW)

0.0603
+0.0135
+(28.85%)
As of 11:32:35 AM EDT. Market Open.
Loading Chart for TOIIW
  • Previous Close 0.0468
  • Open 0.0464
  • Bid --
  • Ask --
  • Day's Range 0.0464 - 0.0603
  • 52 Week Range 0.0464 - 0.0603
  • Volume 4,567
  • Avg. Volume --
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -602.0870
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

theoncologyinstitute.com

825

Full Time Employees

--

Fiscal Year Ends

Recent News: TOIIW

View More

Compare To: TOIIW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TOIIW

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.44%

  • Return on Assets (ttm)

    -19.67%

  • Return on Equity (ttm)

    -213.36%

  • Revenue (ttm)

    393.41M

  • Net Income Avi to Common (ttm)

    -53.01M

  • Diluted EPS (ttm)

    -602.0870

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.67M

  • Total Debt/Equity (mrq)

    3,434.19%

  • Levered Free Cash Flow (ttm)

    -7.46M

Research Analysis: TOIIW

View More

Company Insights: TOIIW

Research Reports: TOIIW

View More

People Also Watch